# Training Program in Cardiac Innovation

> **NIH NIH T32** · UNIVERSITY OF MINNESOTA · 2022 · $400,087

## Abstract

Project Summary
Cardiovascular disease in the American population is continuously a major source of debilitation and death
despite increased prevention, diagnostic, and treatment options. This situation calls for increased scientific
understanding and innovative application of these findings to the care of patients in order to prevent or cure heart
disease. This training program in cardiovascular innovation is designed to teach the scientific and technical skills
necessary to develop a novel idea and carry this idea through to proof of concept in man. The training program
takes unique advantage of the strengths of the Lillehei Heart Institute, the University of Minnesota Cardiovascular
Division, the wider community of translational medicine and entrepreneurship at the University of Minnesota, and
the Twin Cities biotech, pharma, and device industries. This application will train basic and clinical scientists in
an interdisciplinary environment with the goal of giving them the insight and tools to be able to successfully carry
an idea from conception to implementation in man. Therefore, the major goal of this new Training Program is to
provide an interdisciplinary research and training environment wherein trainees will be exposed to the continuum
of technological development from conceptual idea to testing at the basic, small animal, large animal, and human
levels. Trainees will be advantaged by community strengths in basic, translational, and clinical science, training
in cardiovascular innovation and entrepreneurship, and industry interactions and mentorship. There are several
unique features of this training program: 1) a focus on cardiovascular sciences, 2) scientific qualification of its
Trainers, 3) curriculum focused on innovation, 4) presence of industry mentors, and 5) an opportunity for
meaningful industry interactions. The program will consist of a basic cardiovascular curriculum augmented by
specific training in cardiovascular innovation. Each trainee will be required to participate in the Bakken Innovation
Fellows Program. The goal of this program is to train the next leaders in medtech by fostering leadership and
teaching risk management for medical innovations. Trainees will also partake of the Carlson School of
Management Medical Industry Leadership Institute (MILI) program. MILI offers students innovative training,
knowledge, and experiences through industry-specific courses and unique, hands-on evaluations of emerging
technologies from around the globe. Trainees will be required to take 4 relevant half-day courses offered by the
Technological Leadership Institute: 1) Innovation, Leadership & Communication, 2) How to Create and Stimulate
a Culture of Innovation, 3) Communication in a Technical Environment: Developing Writing and Presenting Skills,
and 4) the yearly Innovation Workshop "Becoming a Medical Technology Innovator." Trainees will engage in a
minimum of 3 years of research training. The first two years of training will b...

## Key facts

- **NIH application ID:** 10468262
- **Project number:** 5T32HL144472-04
- **Recipient organization:** UNIVERSITY OF MINNESOTA
- **Principal Investigator:** Peter A Crawford
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $400,087
- **Award type:** 5
- **Project period:** 2019-07-01 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10468262

## Citation

> US National Institutes of Health, RePORTER application 10468262, Training Program in Cardiac Innovation (5T32HL144472-04). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10468262. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*